Correlation Between Pfizer and IShares ESG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and IShares ESG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and IShares ESG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and iShares ESG MSCI, you can compare the effects of market volatilities on Pfizer and IShares ESG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of IShares ESG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and IShares ESG.

Diversification Opportunities for Pfizer and IShares ESG

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and IShares is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and iShares ESG MSCI in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares ESG MSCI and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with IShares ESG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares ESG MSCI has no effect on the direction of Pfizer i.e., Pfizer and IShares ESG go up and down completely randomly.

Pair Corralation between Pfizer and IShares ESG

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the IShares ESG. In addition to that, Pfizer is 2.11 times more volatile than iShares ESG MSCI. It trades about -0.14 of its total potential returns per unit of risk. iShares ESG MSCI is currently generating about 0.33 per unit of volatility. If you would invest  10,091  in iShares ESG MSCI on September 2, 2024 and sell it today you would earn a total of  577.00  from holding iShares ESG MSCI or generate 5.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  iShares ESG MSCI

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
iShares ESG MSCI 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in iShares ESG MSCI are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile basic indicators, IShares ESG may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pfizer and IShares ESG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and IShares ESG

The main advantage of trading using opposite Pfizer and IShares ESG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, IShares ESG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares ESG will offset losses from the drop in IShares ESG's long position.
The idea behind Pfizer Inc and iShares ESG MSCI pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like